Gilead drops after Remdesivir antivirus drug 'flopped' in trials

Gilead drops after Remdesivir reportedly sees poor results, and the market dropped with it. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Guy Adami, Karen Finerman and Steve Grasso.

For more coronavirus live updates:
https://www.cnbc.com/2020/04/23/coronavirus-latest-updates.html

For access to live and exclusive video from CNBC subscribe to CNBC PRO:
https://cnb.cx/2JdMwO7

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

#CNBC
#CNBC TV

Видео Gilead drops after Remdesivir antivirus drug 'flopped' in trials канала CNBC Television